MedPath

山东泽宇生物有限公司

Ownership
-
Established
2020-09-23
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

14

NMPA:14

Drug Approvals

宝宝乐咀嚼片

Approval Number
国药准字Z20070011
Approval Date
Sep 13, 2021
NMPA

Paracetamol Tablets

Product Name
对乙酰氨基酚片
Approval Number
国药准字H37022732
Approval Date
Mar 30, 2020
NMPA

Paracetamol Tablets

Product Name
对乙酰氨基酚片
Approval Number
国药准字H37022733
Approval Date
Mar 30, 2020
NMPA

枇杷叶膏

Approval Number
国药准字Z37020950
Approval Date
Mar 30, 2020
NMPA

板蓝根颗粒

Approval Number
国药准字Z37021323
Approval Date
Mar 30, 2020
NMPA

感冒止咳糖浆

Approval Number
国药准字Z37020937
Approval Date
Mar 30, 2020
NMPA

感冒止咳颗粒

Approval Number
国药准字Z37020936
Approval Date
Mar 30, 2020
NMPA

益母草膏

Approval Number
国药准字Z37021324
Approval Date
Mar 30, 2020
NMPA

新复方大青叶片

Approval Number
国药准字Z37020946
Approval Date
Mar 30, 2020
NMPA

Itopride Hydrochloride Granules

Product Name
盐酸伊托必利颗粒
Approval Number
国药准字H20050932
Approval Date
Mar 14, 2020
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.